Survival, Persistence, and Progressive Differentiation of Adoptively Transferred Tumor-Reactive T Cells Associated with Tumor Regression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival, Persistence, and Progressive Differentiation of Adoptively Transferred Tumor-Reactive T Cells Associated with Tumor Regression

Published:2005-05 Issue:3 Volume:28 Page:258-267
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Huang Jianping,Khong Hung T,Dudley Mark E,El-Gamil Mona,Li Yong F,Rosenberg Steven A,Robbins Paul F

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference30 articles.

1. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.;Dudley;Science,2002

2. Persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy.;Robbins;J Immunol,2004

3. Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions.;Rufer;Blood,2003

4. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool.;Hendriks;J Exp Med,2003

5. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly.;Jones;J Exp Med,2002

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors;Journal for ImmunoTherapy of Cancer;2024-07

2. Long-term efficacy of adoptive cell therapy is determined by host CD8⁺T cells and undermined by lymphodepleting preconditioning;2024-05-21

3. Exploring cellular immunotherapy platforms in multiple myeloma;Heliyon;2024-03

4. Adoptive T-Cell Therapy for the Treatment of Lung Cancer;Immunotherapy Against Lung Cancer;2024

5. DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies;Frontiers in Immunology;2023-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3